Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teruo Shiba

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Diabetes Research and Clinical Practice|October 29, 2003
Improvement of insulin resistance by a new insulin secretagogue, nateglinide--analysis based on the homeostasis modelTeruo Shiba
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 28, 2015
[Mechanisms and efficacy of SGLT2 inhibitors]Teruo Shiba
International Journal of Hematology|October 30, 2022
Chronic cold agglutinin disease after a third COVID-19 mRNA vaccinationYutaro Suzuki, Teruo Shiba
Diabetes Research and Clinical Practice|October 13, 2009
Serum superoxide dismutase activity correlates with the components of metabolic syndrome or carotid artery intima-media thicknessAkihiro Isogawa, Minoru Yamakado, Masao Yano, et al.
Diabetes Research and Clinical Practice|October 23, 2012
Asymptomatic insulinoma: a case report and autopsy seriesSatoru Kishi, Kentaro Sakamoto, Masaya Mori, et al.
Diabetes Research and Clinical Practice|July 29, 2017
Efficacy and safety of empagliflozin in Japanese patients with type 2 diabetes mellitus: A sub-analysis by body mass index and age of pooled data from three clinical trialsTeruo Shiba, So Ishii, Tomoo Okamura, et al.
Diabetes, Obesity & Metabolism|August 28, 2018
Mechanistic insights from sequential combination therapy with a sodium glucose co-transporter-2 inhibitor and a dipeptidyl peptidase-4 inhibitor: Results from the CANARIS Trial using canagliflozin and teneligliptinSumie Okahata, Kentaro Sakamoto, Takako Mitsumatsu, et al.
Endocrine Journal|March 1, 2019
Fulminant type 1 diabetes associated with Isolated ACTH deficiency induced by anti-programmed cell death 1 antibody-insight into the pathogenesis of autoimmune endocrinopathySumie Okahata, Kentaro Sakamoto, Takako Mitsumatsu, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 6, 2009
Cardiac amyloidosis presumptively diagnosed as cardiac syndrome XAtsuhiko Yagishita, Shuzou Tanimoto, Kengo Tanabe, et al.
Journal of Transplantation|December 17, 2011
Knowledge and Demand for Information about Islet Transplantation in Patients with Type 1 DiabetesYuko Yamamoto, Masakazu Nishigaki, Naoko Kato, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Diabetes Research and Clinical Practice|October 29, 2003
Improvement of insulin resistance by a new insulin secretagogue, nateglinide--analysis based on the homeostasis modelTeruo Shiba
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 28, 2015
[Mechanisms and efficacy of SGLT2 inhibitors]Teruo Shiba
International Journal of Hematology|October 30, 2022
Chronic cold agglutinin disease after a third COVID-19 mRNA vaccinationYutaro Suzuki, Teruo Shiba
Diabetes Research and Clinical Practice|October 13, 2009
Serum superoxide dismutase activity correlates with the components of metabolic syndrome or carotid artery intima-media thicknessAkihiro Isogawa, Minoru Yamakado, Masao Yano, et al.
Diabetes Research and Clinical Practice|October 23, 2012
Asymptomatic insulinoma: a case report and autopsy seriesSatoru Kishi, Kentaro Sakamoto, Masaya Mori, et al.
Diabetes Research and Clinical Practice|July 29, 2017
Efficacy and safety of empagliflozin in Japanese patients with type 2 diabetes mellitus: A sub-analysis by body mass index and age of pooled data from three clinical trialsTeruo Shiba, So Ishii, Tomoo Okamura, et al.
Diabetes, Obesity & Metabolism|August 28, 2018
Mechanistic insights from sequential combination therapy with a sodium glucose co-transporter-2 inhibitor and a dipeptidyl peptidase-4 inhibitor: Results from the CANARIS Trial using canagliflozin and teneligliptinSumie Okahata, Kentaro Sakamoto, Takako Mitsumatsu, et al.
Endocrine Journal|March 1, 2019
Fulminant type 1 diabetes associated with Isolated ACTH deficiency induced by anti-programmed cell death 1 antibody-insight into the pathogenesis of autoimmune endocrinopathySumie Okahata, Kentaro Sakamoto, Takako Mitsumatsu, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 6, 2009
Cardiac amyloidosis presumptively diagnosed as cardiac syndrome XAtsuhiko Yagishita, Shuzou Tanimoto, Kengo Tanabe, et al.
Journal of Transplantation|December 17, 2011
Knowledge and Demand for Information about Islet Transplantation in Patients with Type 1 DiabetesYuko Yamamoto, Masakazu Nishigaki, Naoko Kato, et al.
Pageof 2